Davide Cao - Concepedia

Author

Davide Cao

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Carlo Pivato, D Cao, D. Cao, Davide CAO, Davide Cao, Di Cao, Donglan Cao

263

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Cardiovascular Institute of the South Humanitas University University of Florida IRCCS Humanitas Research Hospital

About

Davide Cao is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	644
2	Public Health	5	5	296
3	Health Sciences	2	2	47
4	Engineering	1	1	92
5	Clinical Nutrition	1	1	29

Davide Cao

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients Davide Cao, Roxana Mehran, George Dangas, Journal of the American College of Cardiology ThrombosisContemporary Pci PatientsCardiovascular EpidemiologyCardiovascular DiseaseHealth Policy	2020	206
Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation Giulio Stefanini, Stefan Stortecky, Davide Cao, European Heart Journal	2014	181
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation Roxana Mehran, Davide Cao, Dominick J. Angiolillo, JACC: Cardiovascular Interventions	2021	95
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR Javier Escaned, Davide Cao, Usman Baber, European Heart Journal	2021	94
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach Giulia Luraghi, Francesco Migliavacca, Alberto García‐González, Cardiovascular Engineering and Technology EngineeringFluid-structure InteractionFluid–structure Interaction ApproachValve DiseaseSurgery	2019	92
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey Davide Cao, Rishi Chandiramani, Mauro Chiarito, European Heart Journal Antithrombotic TherapyDrug TherapiesPharmacotherapyCoronary Artery DiseaseAcute Myocardial Infarction	2020	89
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI Marco Valgimigli, Davide Cao, Dominick J. Angiolillo, Journal of the American College of Cardiology	2021	72
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality Cróchán J. O’Sullivan, Lars Englberger, Nicola Hošek, JACC: Cardiovascular Interventions Endovascular TechniqueCardiovascular DiseaseVascular SurgeryValve DiseaseAssigned Treatment Modality	2015	46
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD Giulio Stefanini, Carlo Briguori, Davide Cao, European Heart Journal	2021	37
Types of myocardial injury and mid-term outcomes in patients with COVID-19 Annapoorna Kini, Davide Cao, Matteo Nardin, European Heart Journal - Quality of Care and Clinical Outcomes	2021	37

Page 1